Is TB-500 Legal in Oregon? How to Access It Legally
HealthRX.com
TB-500 is not approved, and Oregon does not change that
See the public record for TB-500
At a glance
- FDA approval / None; no approved drug contains TB-500 [1]
- Pharmacy compounding list / Not listed [2][8]
- Outsourcing-facility list / Not listed [3]
- FDA staff position / July 2026: recommended against adding it [1]
- Advisory committee / July 23, 2026: voted in favor of adding it; advice only [9][4]
- HHS draft policy / October 2026: no enforcement intent against certain compounders of TB-500 acetate injection if conditions are met [4][5]
- Anti-doping / WADA bans thymosin-beta4 and its derivatives at all times [10]
Is TB-500 approved or on FDA's compounding lists?
TB-500 is a synthetic, N-acetylated seven-amino-acid fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4 [1]. FDA's July 2026 review found no USP or National Formulary monograph for it and no FDA-approved drug containing it. It also found no approved product in Canada, Australia, the UK or several European countries, and none authorized by the European Medicines Agency [1].
State-licensed pharmacies may compound only with bulk substances that meet a USP or NF monograph, are components of an FDA-approved drug, or appear on FDA's compounding list [8]. TB-500 meets none of those conditions and sits in none of the three categories on FDA's interim-policy lists, so the category 1 policy does not cover it [2][3][8]. Compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they reach patients [13]. TB-500 appears in the 'nominated but withdrawn' table on FDA's safety-risk page: it was previously in category 2 and its nominator withdrew it, and removal was not a safety finding [11]. FDA's posted concerns are no identified human exposure data, missing safety information, and immunogenicity risk from aggregation and peptide impurities [11].
What changed in 2026
FDA staff proposed in July 2026 that neither the free base nor the acetate be added to the compounding list. They cited inconsistent naming, unclear historical use, no evidence of effectiveness for wound healing, and immunogenicity risk [1]. The Pharmacy Compounding Advisory Committee voted on July 23, 2026 in favor of adding it, against staff's recommendation. That advice is not binding, TB-500 is not on the list, and listing takes formal rulemaking [9][4].
HHS filed a draft policy on October 28, 2026 naming TB-500 among six peptides and covering the acetate form by subcutaneous or intramuscular injection [4][5]. The draft says HHS would not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with TB-500 if its conditions are met, including a single active ingredient and a patient-specific prescription [5]. The notice says it creates no rights and is not binding on HHS or the public. It is not an approval, and it does not put TB-500 on any list [4].
Does Oregon law change the answer?
Oregon Revised Statutes chapter 677 governs medical licensure and practice, including practice across state lines in ORS 677.135 to 677.141 [6]. The Oregon Board of Pharmacy licenses pharmacists and pharmacies and posts disciplinary actions [7]. The federal approval and compounding rules above apply in Oregon, and TB-500 is unapproved and outside the bulk-substance criteria [1][8].
What is known about safety and dose?
There is no approved dose and no human dosing study. The nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for subcutaneous or intramuscular injection [1]. FDA found no published article in which TB-500 was given to a person, and no human pharmacokinetic data [1]. Its adverse-event database search through March 26, 2025 retrieved no TB-500 reports, and FDA found no published case reports [1]. A phase 1 study of full-length thymosin beta-4 included 54 volunteers in its single-dose portion and 30 in its multiple-dose portion; it did not test TB-500 [12].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
Frequently asked questions
Is TB-500 legal in Oregon?
Can a pharmacy compound TB-500 for an Oregon patient?
Has TB-500 been tested in people?
Did the July 2026 advisory vote make TB-500 legal?
Is TB-500 banned in sport?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
Where can I get TB-500?
No legal source is established for buying TB-500. It is not FDA-approved and is on neither FDA compounding list, so pharmacies cannot compound it under the usual criteria. HHS's October 2026 draft policy would cover certain state-licensed pharmacies, federal facilities and licensed physicians if conditions are met, but the draft is not an approval and does not put TB-500 on any list.
Can I take TB-500 on its own?
It is not established whether TB-500 can be taken alone. HHS's draft policy conditions include a single active ingredient and a patient-specific prescription, but the draft is not an approval and creates no rights.
References
Show all 13 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- Official web page.
- Oregon Revised Statutes.
- Oregon Board of Pharmacy : Welcome Page : State of Oregon.
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- Wang X, Liu L, Qi L, Lei C, Li P, Wang Y, et al. A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers. J Cell Mol Med. 2021;25(17):8222-8228.
- U.S. Food and Drug Administration. Human Drug Compounding Laws. Human Drug Compounding Laws | FDA